Cargando…
Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031020/ https://www.ncbi.nlm.nih.gov/pubmed/33827793 http://dx.doi.org/10.1136/bmjgh-2021-005518 |
_version_ | 1783676135899398144 |
---|---|
author | Perehudoff, Katrina 't Hoen, Ellen Boulet, Pascale |
author_facet | Perehudoff, Katrina 't Hoen, Ellen Boulet, Pascale |
author_sort | Perehudoff, Katrina |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8031020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-80310202021-04-27 Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too Perehudoff, Katrina 't Hoen, Ellen Boulet, Pascale BMJ Glob Health Commentary BMJ Publishing Group 2021-04-07 /pmc/articles/PMC8031020/ /pubmed/33827793 http://dx.doi.org/10.1136/bmjgh-2021-005518 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Commentary Perehudoff, Katrina 't Hoen, Ellen Boulet, Pascale Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too |
title | Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too |
title_full | Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too |
title_fullStr | Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too |
title_full_unstemmed | Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too |
title_short | Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too |
title_sort | overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031020/ https://www.ncbi.nlm.nih.gov/pubmed/33827793 http://dx.doi.org/10.1136/bmjgh-2021-005518 |
work_keys_str_mv | AT perehudoffkatrina overridingdrugandmedicaltechnologypatentsforpandemicrecoveryalegitimatemoveforhighincomecountriestoo AT thoenellen overridingdrugandmedicaltechnologypatentsforpandemicrecoveryalegitimatemoveforhighincomecountriestoo AT bouletpascale overridingdrugandmedicaltechnologypatentsforpandemicrecoveryalegitimatemoveforhighincomecountriestoo |